Microvascular decompression for classic trigeminal neuralgia recurrence after percutaneous rhizotomy procedures
EANS Academy. Fedirko V. Sep 26, 2019; 276036; EP07025
Prof. Volodymyr Fedirko
Prof. Volodymyr Fedirko

Access to this content is reserved for EANS members and attendees of this event. Click here to become an EANS member and gain your access to the full content of the EANS Academy

Discussion Forum (0)
Rate & Comment (0)
Background: rhizotomy procedures for classic trigeminal neuralgia (CTN), even being rather successful, have not negligible rate of failure and pain recurrence. Hence it could be necessary to perform another intervention. As available data regarding CTN recurrence's management are very scarce, our study aimed to investigate whether the efficacy and safety of CTN-gold-standard management — microvascular decompression (MVD) were influenced by prior percutaneous rhizotomy procedures (PRP).
Methods: retrospective evaluation of 28 consecutive patients who underwent MVD for CTN recurrence after PRP during 2015-2016 yy. Treatment results, outcomes and intraoperative findings were categorized and statistically analyzed in comparison with control group of 66 MVD patients without any prior procedures. Barrow Neurological Institute (BNI) scores were used.
Results: Operative findings: trigeminal nerve atrophy and decoloration was seen in 9 patients (32%); sick arachnoid adhesions with nerve root distortions - in 13 cases (46,7%); «milky» arachnoid opacity - in 5 (17,8%); no offending vessel detected in 1 case (3,6%). Postoperative average BNI Pain Score was 2,21 not statistically different in comparison with group without prior rhizotomy - 1,95 (significant proportion of BNI Pain Score 3 because of gradual anticonvulsants withdrawal). At last follow-up BNI Pain Score was lower in pure MVD group (1,43 vs 2,43; P = 0,0006 95% CI 0,5918 to 1,9987). BNI Numbness Score and other neuropathy indicators were higher in group with prior rhizotomy (2,5 vs 1,3; P < 0,0001 95% CI 0,6697 to 1,6541). Among them 100% had clinically significant neuropathy and 57% had had dysesthesias in contrast to 27% and 7% in pure MVD group respectively. New or worsened neuropathy signs manifested in 5 patients (17,9%).
Conclusions: Being more pathogenically justified MVD remains the procedure of choice for patients with recurrent CTN after PRP with additional risks of neuropathy, probably caused by destructive nature of rhizotomy procedures.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings